» Articles » PMID: 34479542

Considerations of Australian Community Pharmacists in the Provision and Implementation of Cognitive Pharmacy Services: a Qualitative Study

Overview
Publisher Biomed Central
Specialty Health Services
Date 2021 Sep 4
PMID 34479542
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Australian federally-funded cognitive pharmacy services (CPS) (e.g. medication management and reconciliation services) have not been translated into practice consistently. These health services are purportedly accessible across all Australian community pharmacies, yet are not delivered as often as pharmacists would like. There are international indicators that pharmacists lack the complete behavioural control required to prioritise CPS, despite their desire to deliver them. This requires local investigation.

Objective: To explore Australian pharmacists' perspectives [1] as CPS providers on the micro level, and [2] on associated meso and macro level CPS implementation issues.

Methods: Registered Australian community pharmacists were recruited via professional organisations and snowball sampling. Data were collected via an online demographic survey and semi-structured interviews until data saturation was reached. Interview transcripts were de-identified then verified by participants. Content analysis was performed to identify provider perspectives on the micro level. Framework analysis using RE-AIM was used to explore meso and macro implementation issues.

Results: Twenty-three participants across Australia gave perspectives on CPS provision. At the micro level, pharmacists did not agree on a single definition of CPS. However, they reported complexity in interactional work and patient considerations, and individual pharmacist factors that affected them when deciding whether to provide CPS. There was an overall deficiency in pharmacy workplace resources reported to be available for implementation and innovation. Use of an implementation evaluation framework suggested CPS implementation is lacking sufficient structural support, whilst reach into target population, service consistency and maintenance for CPS were not specifically considered by pharmacists.

Conclusions: This analysis of pharmacist CPS perspectives suggests slow uptake may be due to a lack of evidence-based, focused, multi-level implementation strategies that take ongoing pharmacist role transition into account. Sustained change may require external change management and implementation support, engagement of frontline clinicians in research, and the development of appropriate pharmacist practice models to support community pharmacists in their CPS roles.

Trial Registration: This study was not a clinical intervention trial. It was approved by the University of Technology Sydney Human Research Ethics Committee (UTS HREC 19-3417) on the 26th of April 2019.

Citing Articles

Pharmacy stakeholders' views and experiences of the credentialing of advanced or specialist pharmacist practice: A mixed methods systematic review.

Deasy E, Seoighe A, Ryan C, Byrne S, Dalton K Explor Res Clin Soc Pharm. 2024; 16:100522.

PMID: 39624069 PMC: 11609238. DOI: 10.1016/j.rcsop.2024.100522.


Prescription for change: Unveiling burnout perspectives among pharmacy leaders.

Kiriazopoulos S, Perepelkin J, Alford H Can Pharm J (Ott). 2024; 158(2):98-109.

PMID: 39619259 PMC: 11607704. DOI: 10.1177/17151635241293785.


Privacy in Community Pharmacies in Saudi Arabia: A Cross-Sectional Study.

Alrasheed M, Alfageh B, Almohammed O Healthcare (Basel). 2024; 12(17).

PMID: 39273764 PMC: 11394820. DOI: 10.3390/healthcare12171740.


Australian community pharmacy service provision factors, stresses and strains: A qualitative study.

Yong F, Hor S, Bajorek B Explor Res Clin Soc Pharm. 2023; 9:100247.

PMID: 37008896 PMC: 10063403. DOI: 10.1016/j.rcsop.2023.100247.


Barriers and Facilitators Influencing Real-time and Digital-Based Reporting of Adverse Drug Reactions by Community Pharmacists: Qualitative Study Using the Task-Technology Fit Framework.

Tagne J, Yakob R, Mcdonald R, Wickramasinghe N Interact J Med Res. 2022; 11(2):e40597.

PMID: 36222800 PMC: 9597424. DOI: 10.2196/40597.


References
1.
Radwin L . 'Knowing the patient': a review of research on an emerging concept. J Adv Nurs. 1996; 23(6):1142-6. DOI: 10.1046/j.1365-2648.1996.12910.x. View

2.
Yong F, Garcia-Cardenas V, Williams K, Charlie Benrimoj S . Factors affecting community pharmacist work: A scoping review and thematic synthesis using role theory. Res Social Adm Pharm. 2019; 16(2):123-141. DOI: 10.1016/j.sapharm.2019.05.001. View

3.
Bush J, Langley C, Wilson K . The corporatization of community pharmacy: implications for service provision, the public health function, and pharmacy's claims to professional status in the United Kingdom. Res Social Adm Pharm. 2009; 5(4):305-18. DOI: 10.1016/j.sapharm.2009.01.003. View

4.
Doucette W, Rippe J, Gaither C, Kreling D, Mott D, Schommer J . Influences on the frequency and type of community pharmacy services. J Am Pharm Assoc (2003). 2016; 57(1):72-76.e1. DOI: 10.1016/j.japh.2016.08.008. View

5.
Hossain L, Fernandez-Llimos F, Luckett T, Moullin J, Durks D, Franco-Trigo L . Qualitative meta-synthesis of barriers and facilitators that influence the implementation of community pharmacy services: perspectives of patients, nurses and general medical practitioners. BMJ Open. 2017; 7(9):e015471. PMC: 5588935. DOI: 10.1136/bmjopen-2016-015471. View